Cognite Awarded Contracts with Statnett, Norwegian State Owned Grid Operator, to Deliver Data Contextualization Platform and Digital Solutions within Smart Asset Management and Power System Analysis
10.2.2021 08:04:00 CET | Business Wire | Press Release
Cognite has been awarded three contracts by Statnett, the system operator of the Norwegian power system, to develop and deliver a data contextualization platform and digital solutions within the areas of Power System Analysis and Smart Asset Management.
By selecting Cognite, Statnett gains access to scalable, cloud-based technology that will help the grid operator achieve its ambitious digitalization goals. The energy transition depends in part on a robust power grid that can integrate new sources of renewable energy and handle the growing electrification of society. Liberated, contextualized data will help power that transition.
“This partnership strengthens our ambition to become more data-driven in our decision-making processes. We’re developing digital solutions and making them available to our core business, which will help us boost our efficiency, improve our customer response time, and reduce costs,” said Beate Sander Krogstad, Executive Vice President for IT at Statnett.
Cognite and Statnett have over the past two years participated in a research and development project to find better and more efficient ways to query and handle data in the power system domain. The R&D collaboration uncovered a need for a data contextualization platform, a software solution that combines data and metadata from different sources and systems.
As part of the contracts awarded by Statnett, Cognite’s industrial DataOps platform, Cognite Data Fusion, will be used as part of Statnett's data platform. More than 50 industrial companies worldwide, among them Hafslund E-CO, Aker BP and OMV, are using Cognite Data Fusion to operate and produce smarter, safer, and more sustainably. For Statnett, Cognite Data Fusion will give applications and analysts easy access to contextualized data, and enable Statnett to develop new, relevant applications at the top of the contextualization platform.
“Cognite’s solutions can help digitalize the power and utilities industry, and Statnett will now be able to incorporate these solutions into its operations. As this partnership kicks off, I would also like to extend an invitation to other interested parties to reach out so that we can explore further opportunities for collaboration,” said John Markus Lervik, CEO of Cognite.
Faster analysis, smarter maintenance
One of the areas where Cognite’s solutions will be used is in Power System Analysis (PSA). As the electrification of society accelerates, grid operators such as Statnett need to be able to connect new power generation systems and consumers to the grid in a safe and efficient manner. To process grid connection applications, analysts need to examine large quantities of data to determine whether the grid must be upgraded to handle the increased load.
With all the relevant information needed to process grid connection applications accessible in one location, Statnett’s analysts can more efficiently process grid connection applications. This will streamline Statnett’s workflows and help the grid operator assist customers throughout the connection process.
Cognite will also contribute technology for Smart Asset Management (SAM). Today, Statnett conducts regular maintenance of transformers, power lines, gas-insulated substations, and the other components that form the power grid. With improved access to contextualized data in Cognite Data Fusion, Statnett can better determine the condition of the various components and how it will change over time.
Cognite’s bid for the contracts was awarded the highest overall score as part of the open request for proposals (RFP) process. Cognite’s bid exhibited a high level of expertise and met Statnett’s technical and security-related requirements.
About Cognite
Cognite is a global industrial software-as-a-service (SaaS) company supporting the full-scale digital data driven transformation of heavy-asset industries around the world. Our core product, Cognite Data Fusion (CDF), is an industrial data operations and contextualization platform, putting raw data into real-world industrial context, enabling rapid application & solution creation at scale. CDF powers companies with contextualized OT/IT/ET data to develop solutions that increase safety, sustainability, efficiency, and drive revenue. Visit us at www.cognite.com and follow us on Twitter @CogniteData or at LinkedIn: https://www.linkedin.com/company/cognitedata
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210209006336/en/
Contact information
Michelle Holford
Global PR Lead, Cognite
+1 (512) 744-3420 (US)
+47 482 90 454 (Norway)
michelle.holford@cognite.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press Release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press Release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom